Literature DB >> 25649777

The return-to-play incentive and the effect of motivation on neuropsychological test-performance: implications for baseline concussion testing.

Amanda R Rabinowitz1, Victoria C Merritt, Peter A Arnett.   

Abstract

Athletes may be less engaged in baseline cognitive testing in the absence of a powerful return-to-play incentive. The present study sought to evaluate whether athletes' level of motivation (1) influences baseline test performance and (2) changes across pre- and post-injury assessments. We found a significant relationship between examiners' ratings of athletes motivation toward testing and baseline cognitive test performance. Athletes, but not controls, demonstrated increased motivation between tests. These findings suggest that baseline test performance may underestimate true premorbid abilities for a subset of athletes.

Mesh:

Year:  2015        PMID: 25649777     DOI: 10.1080/87565641.2014.1001066

Source DB:  PubMed          Journal:  Dev Neuropsychol        ISSN: 1532-6942            Impact factor:   2.253


  4 in total

Review 1.  Validity of the Immediate Post Concussion Assessment and Cognitive Testing (ImPACT).

Authors:  Bara Alsalaheen; Kayla Stockdale; Dana Pechumer; Steven P Broglio
Journal:  Sports Med       Date:  2016-10       Impact factor: 11.136

Review 2.  Neuropsychological Assessment Following Concussion: an Evidence-Based Review of the Role of Neuropsychological Assessment Pre- and Post-Concussion.

Authors:  Anthony P Kontos; Alicia Sufrinko; Melissa Womble; Nathan Kegel
Journal:  Curr Pain Headache Rep       Date:  2016-06

3.  Baseline Neurocognitive Performance and Clearance for Athletes to Return to Contact.

Authors:  Breton M Asken; James R Clugston; Aliyah R Snyder; Russell M Bauer
Journal:  J Athl Train       Date:  2016-12-01       Impact factor: 2.860

4.  Prospective Exploration of Cognitive-Communication Changes With Woodcock-Johnson IV Before and After Sport-Related Concussion.

Authors:  Kathryn Y Hardin
Journal:  Am J Speech Lang Pathol       Date:  2021-03-30       Impact factor: 2.408

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.